BioTelemetry (NSDQ:BEAT) said today it will pay $7 million in cash to pick up Telcare Medical Supply, which it said was the 1st company to receive FDA clearance for a cellular-enabled blood glucose monitoring system. The deal will include $7 million in cash up front with the potential for an additional $5 million in performance-based earn-outs, […]
Ex-FDA chief Hamburg moves to Institute of Medicine | Personnel Moves
Dr. Margaret Hamburg, who resigned as FDA commissioner in February, was named foreign secretary of the U.S. Institute of Medicine this week.
Hamburg spent 6 years leading the federal safety watchdog, overseeing a massive revamp of its medical device, drug, food and tobacco regulation.
Diabetes: EuroZone regulators OK Telcare’s wireless blood glucose meter
Telcare this week got the green light to market its cellphone-enabled blood glucose meter in the European Union, the Bethesda, Md.-based company announced.
The device, the first FDA-cleared mHealth glucose meter, connects patients and caregivers in real time with actionable data, according to a press release.
Wright Medical announces $200M debt offering | Wall Street Beat
Wright Medical (NSDQ:WMGI) said it’s planning a private placement for $200 million worth of senior notes due 2017.
Docs resist prostate test recommendation | MassDevice.com On Call
MASSDEVICE ON CALL — Primary care docs surveyed by Johns Hopkins University researchers say they’re unlikely to curtail their use of a test to detect prostate cancer, despite recommendations from the U.S. Preventive Services Task Force.
The USPSTF stirred up a controversy last year when it suggested that routine prostate-specific antigen tests for healthy men might do more harm than good.
Diabetes: WSJ’s Mossberg raves about Telcare’s web-friendly glucose monitor
Telcare Inc. got high marks for its cellular-enabled glucose monitor from the Wall Street Journal’s personal technology columnist, Walt Mossberg.
While he didn’t love the outdated look of the device, which he describes as looking like a "thick, old cellphone," he called the Telcare system "a leap ahead of nearly all glucose meters."
The Telcare BGM is a 3G wireless-enabled glucose meter that can sent instantly send readings to a password-protected website, which can then be shared with doctors or family members, or to an iPhone app.
St. Jude enrolls first patient into heart rhythm early intervention trial | Regulatory Roundup
St. Jude Medical Inc. (NYSE:STJ) enrolled the first patient into its pan-European study of early interventions of irregular heartbeat.
St. Jude can enroll more than 3,000 patients across 200 centers in Europe, including locations in Belgium, the Czech Republic, Denmark, France, Germany, Italy, the Netherlands, Poland, Spain, Switzerland and the United Kingdom.
